DEVELOPMENT AND MANUFACTURING COLLABORATION AGREEMENT by and between VIR BIOTECHNOLOGY, INC. and WUXI BIOLOGICS (HONG KONG) LIMITED 25 February 2020Development and Manufacturing Collaboration Agreement • July 6th, 2020 • Vir Biotechnology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 6th, 2020 Company Industry JurisdictionThis Development and Manufacturing Collaboration Agreement (this “Agreement”) is made effective as of February 25, 2020 (the “Effective Date”) by and between Vir Biotechnology, Inc., a Delaware corporation having an address at 499 Illinois Street, San Francisco, CA 94158 USA (“Vir”), and WuXi Biologics (Hong Kong) Limited., a Hong Kong corporation with a place of business at Building 1, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China 200131 (“WuXi”). Vir and WuXi are each hereafter referred to individually as a “Party” and together as the “Parties.”